Lamotrigine use in treatment refractory depression in adolescents

Trial Profile

Lamotrigine use in treatment refractory depression in adolescents

Discontinued
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 22 May 2017

At a glance

  • Drugs Lamotrigine (Primary) ; Fluoxetine; Sertraline
  • Indications Bipolar disorders; Major depressive disorder
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 May 2017 Status changed from suspended to discontinued.
    • 08 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top